Cargando…

HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review

As there are millions of cancer deaths every year, it is of great value to identify applicable prognostic biomarkers. As an important alarm, the prognostic role of high mobility group box 1 (HMGB1) in cancer remains controversial. We aim to assess the association of HMGB1 expression with prognosis i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tengyun, Zhang, Wei, Yang, Geliang, Li, Huijun, Chen, Qi, Song, Ruixiang, Zhao, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226592/ https://www.ncbi.nlm.nih.gov/pubmed/27391431 http://dx.doi.org/10.18632/oncotarget.10413

Ejemplares similares

Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
por: Bao, Guoqiang, et al.
Publicado: (2010)

Overexpression of HMGB3 and its prognostic value in breast cancer
por: Zhou, Xiaomei, et al.
Publicado: (2022)

Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis
por: Mo, Huaqing, et al.
Publicado: (2021)

Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis
por: Zhao, Hao, et al.
Publicado: (2022)

Overexpression of CsHMGB Alleviates Phytotoxicity and Propamocarb Residues in Cucumber
por: Li, Shengnan, et al.
Publicado: (2020)

HMGB1 overexpression promotes a malignant phenotype and radioresistance in ESCC
por: Dong, Jing, et al.
Publicado: (2022)

The prognostic significance of hTERT overexpression in cancers: A systematic review and meta-analysis
por: Wang, Kai, et al.
Publicado: (2018)

Yoga for prenatal depression: a systematic review and meta-analysis
por: Gong, Hong, et al.
Publicado: (2015)

The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer
por: Li, Pan, et al.
Publicado: (2019)

Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes
por: Yang, Qi, et al.
Publicado: (2015)

Effects of HMGB-1 Overexpression on Cell-Cycle Progression in MCF-7 Cells
por: Yoon, Sarah, et al.
Publicado: (2004)

CTSE Overexpression Is an Adverse Prognostic Factor for Survival among Rectal Cancer Patients Receiving CCRT
por: Chou, Chia-Lin, et al.
Publicado: (2021)

Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis
por: Zhao, Haiyue, et al.
Publicado: (2018)

Leptin Overexpression as a Poor Prognostic Factor for Colorectal Cancer
por: Li, Chunxiang, et al.
Publicado: (2020)

Effects of Phospholipase Dε Overexpression on Soybean Response to Nitrogen and Nodulation
por: Yao, Shuaibing, et al.
Publicado: (2022)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis
por: Cheng, Wei, et al.
Publicado: (2018)

Clinicopathological and Prognostic Significance of CD24 Overexpression in Patients with Gastric Cancer: A Meta-Analysis
por: Wu, Jing-Xun, et al.
Publicado: (2014)

Prognostic Impact of Epidermal Growth Factor Receptor Overexpression in Patients with Cervical Cancer: A Meta-Analysis
por: Tian, Wei-Jie, et al.
Publicado: (2016)

Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis
por: Wei, Yao, et al.
Publicado: (2015)

Value of HMGB1 expression for assessing gastric cancer severity: a systematic meta-analysis
por: Zhou, Chunxiang, et al.
Publicado: (2021)

Escin suppresses HMGB1‐induced overexpression of aquaporin‐1 and increased permeability in endothelial cells
por: Chen, Changjun, et al.
Publicado: (2019)

Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
por: Tabata, Chiharu, et al.
Publicado: (2013)

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
por: Liikanen, Ilkka, et al.
Publicado: (2015)

A Dual-Role of Gu-4 in Suppressing HMGB1 Secretion and Blocking HMGB1 Pro-Inflammatory Activity during Inflammation
por: Zhou, HuiTing, et al.
Publicado: (2014)

Prognostic factors for overall survival after surgical resection in patients with thymic epithelial tumors: A systematic review and meta-analysis
por: Li, Jiaduo, et al.
Publicado: (2022)

HMGB1 Is a Prognostic Factor for Mortality in Acute Kidney Injury Requiring Renal Replacement Therapy
por: Matsuura, Ryo, et al.
Publicado: (2023)

Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis
por: Kang, Shengwei, et al.
Publicado: (2022)

PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis
por: Xu, Ming, et al.
Publicado: (2019)

Survival and prognostic factors in hypertrophic cardiomyopathy: a meta-analysis
por: Liu, Qun, et al.
Publicado: (2017)

Prognostic value of LAMP3 and TP53 overexpression in benign and malignant gastrointestinal tissues
por: Sun, Rongwei, et al.
Publicado: (2014)

Prognostic value of NEK2 overexpression in digestive system cancers: a meta-analysis and systematic review
por: Ren, Qian, et al.
Publicado: (2018)

NIMA-related kinase 2 overexpression is associated with poor survival in cancer patients: a systematic review and meta-analysis
por: Yao, Yang, et al.
Publicado: (2019)

HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021)

Correction: The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer
Publicado: (2020)

Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis
por: Ren, Fanghui, et al.
Publicado: (2015)

Systematic analysis of expression profiles of HMGB family members for prognostic application in non-small cell lung cancer
por: Zheng, Xuefeng, et al.
Publicado: (2022)

HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma
por: Yang, Zhangsheng, et al.
Publicado: (2022)

Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis
por: Zhao, Xiaotong, et al.
Publicado: (2016)

Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma
por: Wei, Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_53o0pfpvj80duudrskke6ohfh3